Consumer Brands Shake Things Up...With Mergers
2025 has been quite the year for consumer brands, but not in a good way. The industry has underperformed for the past three years and many of the world's largest consumer brand companies are resorting to mergers & acquisitions, asset sales, and spin-offs to rejuvenate their prospects.
Court Rejects Bid To Block Kenvue's $398 Million Shareholder Payout In Tylenol Safety Dispute - Kenvue ( NYSE:KVUE )
On Friday, a Texas judge declined to halt an upcoming shareholder payout by Texas Attorney General Ken Paxton to restrict Kenvue Inc.'s ( NYSE:KVUE ) handling and marketing of Tylenol amid ongoing litigation over the product's safety for pregnant women.
Kimberly-Clark, Thermo Fisher Scientific On CNBC's 'Final Trades' - Kimberly-Clark ( NASDAQ:KMB ) , Thermo Fisher Scientific ( NYSE:TMO )
On CNBC's "Halftime Report Final Trades," Jenny Van Leeuwen Harrington, CEO of Gilman Hill Asset Management, LLC, picked Kimberly-Clark Corporation ( NYSE:KMB ) . "[Kimberly-Clark] is still oversold after the Kenvue announcement," Harrington says, citing its 5% dividend yield.
Decoding Johnson & Johnson's Options Activity: What's the Big Picture? - Johnson & Johnson ( NYSE:JNJ )
Whales with a lot of money to spend have taken a noticeably bullish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson ( NYSE:JNJ ) we detected 8 trades.
2 Strong Healthcare Stock Picks for Dividend Investors
These top dividend payers could enrich a long-term investor's portfolio.
3 Beaten-Down Stocks That Haven't Been This Cheap in Over 5 Years
These stocks are down between 20% and 57% this year.
Want Safe Dividend Income in 2025 and Beyond? Invest in the Following 3 Ultra-High-Yield Stocks.
Ultra-high yields don't have to translate to ultra-high risk.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Kenvue Inc. ( NYSE - KVUE ) , Sonida Senior Living, Inc. ( NYSE - SNDA ) , Evoke Pharma Inc. ( Nasdaq - EVOK ) , SM Energy Company ( NYSE - SM )
BALA CYNWYD, Pa., Nov. 05, 2025 ( GLOBE NEWSWIRE ) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.
Halper Sadeh LLC Encourages CDE, SM, KMB, GES Shareholders to Contact the Firm to Discuss Their Rights - Guess ( NYSE:GES ) , Coeur Mining ( NYSE:CDE )
NEW YORK, Nov. 05, 2025 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Halper Sadeh LLC Encourages WOW, PINC, KVUE Shareholders to Contact the Firm to Discuss Their Rights - Kenvue ( NYSE:KVUE ) , Premier ( NASDAQ:PINC )
NEW YORK, Nov. 05, 2025 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Kenvue Inc. ( NYSE: KVUE )
NEW YORK, Nov. 04, 2025 ( GLOBE NEWSWIRE ) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC ( the "M&A Class Action Firm" ) , has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report.
Kenvue's $48.7B Sale Puts Consumer Staples ETFs Back In Vogue - Kenvue ( NYSE:KVUE )
Consumer staples ETFs, usually the quiet corner of the market, are suddenly in the spotlight. The $48.7 billion acquisition of Kenvue Inc. ( NYSE:KVUE ) by Kimberly-Clark Corp ( NASDAQ:KMB ) has stirred renewed interest in the sector, setting up a potential reshuffling of weightings across ...
Halper Sadeh LLC Encourages JAMF, KVUE, IMXI, KMB Shareholders to Contact the Firm to Discuss Their Rights - Jamf Holding ( NASDAQ:JAMF ) , International Money ( NASDAQ:IMXI )
NEW YORK, Nov. 04, 2025 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
These 2 Dividend Kings Are Combining in a $48.7 Billion Megadeal. Is It A Win-Win for Dividend Investors?
Kimberly-Clark is creating a consumer health and wellness giant.
Palantir, Kimberly-Clark, Hims & Hers, Navitas And Cipher Mining: Why These 5 Stocks Are On Investors' Radars Today - Palantir Technologies ( NASDAQ:PLTR )
On Monday, major U.S. indexes showed mixed performance - the Dow Jones Industrial Average slipped nearly 0.5% to 47,336.68, while the S&P 500 edged up 0.2% to 6,851.97. The Nasdaq closed 0.46% higher at 23,834.72. These are the top stocks that gained the attention of retail traders and investors ...
Does the Market Have Bad Breadth?
Is the breadth in this market, or lack thereof, a sign of weakening trading sentiment?
Options Corner: Kimberly-Clark's Implosion Offers An Unusual Informational Arbitrage Opportunity - Kimberly-Clark ( NASDAQ:KMB )
Kimberly-Clark Corporation ( NASDAQ:KMB ) rattled its shareholders when it earlier announced its acquisition of consumer goods giant Kenvue Inc ( NYSE:KVUE ) . Ordinarily, such an acquisition might make sense due to the implied expansion of the acquiring entity's product portfolio.
KVUE Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of Kenvue to Kimberly-Clark - Kenvue ( NYSE:KVUE )
MONSEY, N.Y., Nov. 03, 2025 ( GLOBE NEWSWIRE ) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Kenvue Inc. ( NYSE:KVUE ) ( "Kenvue" ) to Kimberly-Clark pursuant to which Kenvue shareholders will receive $3.50 per share in cash as well as 0.14625 ...
Why Kimberly-Clark Stock Just Dropped
Kimberly-Clark stock could be incredibly cheap after its merger.
Pre-Markets Mixed to Start November
Pre-market futures are mixed this morning as major indexes seek some equilibrium after striking - then pulling slightly back from - all-time trading highs at various times last month.
Why Tylenol Maker Kenvue Stock Just Popped
Kenvue's value isn't obvious -- but a merged Kenvue and Kimberly-Clark might be a buy.
Pre-markets Mixed on Big Staples Acquisition
The blue-chip Dow and the small-cap Russell 2000 are both down at this hour, but the Nasdaq and S&P 500 are up.
Kimberly-Clark, Vertex And Other Big Stocks Moving Lower In Monday's Pre-Market Session - ALPS Group ( NASDAQ:ALPS ) , Alvotech ( NASDAQ:ALVO )
U.S. stock futures were mixed this morning, with the Nasdaq futures gaining more than 100 points on Monday. Shares of Kimberly-Clark Corporation ( NYSE:KMB ) fell sharply in pre-market trading after the company announced it will acquire Kenvue in a cash and stock transaction with an enterprise ...
Kimberly-Clark agrees to buy Tylenol owner Kenvue in $48.7 billion deal, creating consumer staples giant
The combined company would bring together brands like Huggies and Kleenex with the likes of Band-Aid and Tylenol.
Kimberly-Clark Stock Plunges Over 16%, Kenvue Surges 20% In Monday Pre-Market: What's Going On? - Kimberly-Clark ( NASDAQ:KMB ) , Johnson & Johnson ( NYSE:JNJ )
Shares of Kimberly-Clark Corporation ( NASDAQ:KMB ) plunged 16.15% during the pre-market trading session on Monday, after it announced the acquisition of Kenvue Inc. ( NYSE:KVUE ) on Monday. Meanwhile Kenvue stock surged 20.04%.
Will President Trump's Tylenol Claims Hurt These 2 Leading Pharmaceutical Stocks?
Even though Kenvue's stock was already in a tailspin before the FDA warned pregnant woman that Tylenol posed a health risk, there are still some lingering impacts to consider.
These 3 Dividend Stocks Yield More Than 5% and Have Payout Ratios Over 100%. Are Dividend Cuts Coming?
A high payout ratio can be concerning, but that doesn't always mean the dividend in question is destined to be cut.
Earnings Preview: Kenvue ( KVUE ) Q3 Earnings Expected to Decline
Kenvue (KVUE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nvidia To Rally Around 37%? Here Are 10 Top Analyst Forecasts For Wednesday - Apple ( NASDAQ:AAPL ) , Cheesecake Factory ( NASDAQ:CAKE )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Rosenblatt cut Stagwell Inc. ( NASDAQ:STGW ) price target from $10 to $9.
This Stride Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Alexandria Real Estate ( NYSE:ARE ) , Brookfield Infr Partners ( NYSE:BIP )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Ken Paxton Alleges Johnson & Johnson Misled Mothers On Tylenol Safety Ken Paxton Sues Johnson & Johnson Over Tylenol Safety Issues Among Pregnant Women - Johnson & Johnson ( NYSE:JNJ ) , Kenvue ( NYSE:KVUE )
Texas Attorney General Ken Paxton has filed a lawsuit against Johnson & Johnson ( NYSE:JNJ ) and Kenvue Inc ( NYSE:KVUE ) , accusing the companies of misleading pregnant women about the safety of Tylenol despite evidence suggesting its active ingredient, acetaminophen, may increase the risk of ...
Renaissance Capital Bets Big on Tylenol and Kenvue ( KVUE ) By Purchasing Over 351,000 Shares
According to a filing with the U.S. Securities and Exchange Commission dated October 20, 2025, Renaissance Capital LLC increased its position in Kenvue by 351,259 shares in Q3 2025. The estimated value of the shares acquired, based on the average closing price for the quarter, was approximately ...
3 Healthcare Stocks Paying the Highest Dividends of 2025
If you are looking for high yields in the healthcare sector, here are three choices. Make sure you understand the risks before you buy them.
Got $1,000? 3 High-Yield Healthcare Stocks to Buy and Hold Forever.
Looking at high-yield healthcare stocks? These three stand out (but one has a slight skew to its story).
Looking Into Kenvue Inc's Recent Short Interest - Kenvue ( NYSE:KVUE )
Kenvue Inc's ( NYSE:KVUE ) short interest as a percent of float has fallen 20.2% since its last report. According to exchange reported data, there are now 34.24 million shares sold short, which is 2.37% of all regular shares that are available for trading.
3 Dividend Stocks With 5% ( or Higher ) Yields to Buy Hand Over Fist in October
These three stocks have elevated yields and attractive dividend histories.
Meet the 5%-Yielding Dividend Stock That Could Soar in 2026
Kenvue could start to recover in 2026.
How Starboard could build value at Keurig Dr Pepper ahead of its JDE Peet deal
Starboard has taken a position in Keurig Dr Pepper and has held meetings with the company's management.
Revolution Medicines, Disc Medicine, American Express And Other Big Stocks Moving Higher On Friday - American Express ( NYSE:AXP ) , AppFolio ( NASDAQ:APPF )
U.S. stocks were mostly higher, with the Dow Jones index gaining more than 150 points on Friday.
Why Kenvue Stock Tumbled by 13% on Thursday
The company's baby powder product is under legal fire once again.
J&J Bets on MedTech Growth With Orthopaedics Unit Spin-Off Plan
J&J's surprise plan to spin off its Orthopaedics unit as DePuy Synthes is aimed at sharpening MedTech focus and boosting growth margins.
Johnson & Johnson, Kenvue Named In First Ever UK Legal Action Over Talc Cancer Claims - Johnson & Johnson ( NYSE:JNJ )
Thousands of claimants in the U.K. are suing Johnson & Johnson ( NYSE:JNJ ) , accusing the healthcare giant of knowingly selling asbestos-contaminated talcum powder that allegedly caused cancer in consumers.
Decoding Kenvue's Options Activity: What's the Big Picture? - Kenvue ( NYSE:KVUE )
Investors with a lot of money to spend have taken a bullish stance on Kenvue ( NYSE:KVUE ) . We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.
2 Ultra-High-Yield Dividend Stocks With Total Return Potential of Up to 41% in 12 Months, According to Select Wall Street Analysts
Juicy dividends are only part of the attraction with these beaten-down stocks.
This 2.7%-Yielding Dividend King Remains One of the Healthiest Income Stocks You Can Buy
Johnson & Johnson has a very healthy financial profile and growth prospects.
Looking At Johnson & Johnson's Recent Unusual Options Activity - Johnson & Johnson ( NYSE:JNJ )
Financial giants have made a conspicuous bearish move on Johnson & Johnson. Our analysis of options history for Johnson & Johnson ( NYSE:JNJ ) revealed 25 unusual trades. Delving into the details, we found 24% of traders were bullish, while 56% showed bearish tendencies.
Kenvue Unusual Options Activity - Kenvue ( NYSE:KVUE )
Deep-pocketed investors have adopted a bearish approach towards Kenvue ( NYSE:KVUE ) , and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.
Johnson & Johnson Q3 Preview: With Stock Near All-Time Highs, Here's What To Watch - Johnson & Johnson ( NYSE:JNJ )
Health care giant Johnson & Johnson ( NYSE:JNJ ) has had a good year with its shares trading near all-time highs. The company looks to keep a trend of beating analyst estimates when third-quarter financial results are reported before market open Tuesday.
5 Consumer Staples Stocks That Are Feeling the Effects of President Trump's Tariffs
Consumer staples companies are typically more resilient to macroeconomic headwinds than their peers, but in the past six months, tariffs have trampled the sector.
Buying J&J Stock Ahead of Q3 Earnings? Here's What You Should Know
J&J gears up for Q3 results with solid gains from Darzalex, Tremfya and MedTech, even as Stelara faces fierce biosimilar pressure.
